141 related articles for article (PubMed ID: 15454241)
1. New N-pyridinyl(methyl)-indolalkanamides acting as topical inflammation inhibitors.
Dassonville A; Bretéché A; Evano J; Duflos M; le Baut G; Grimaud N; Petit JY
Bioorg Med Chem Lett; 2004 Nov; 14(21):5441-4. PubMed ID: 15454241
[TBL] [Abstract][Full Text] [Related]
2. N-Pyridinyl(methyl)-indole-1- or 3-propanamides and propenamides acting as topical and systemic inflammation inhibitors.
Dassonville A; Lardic M; Breteche A; Nourrisson MR; Le Baut G; Grimaud N; Petit JY; Duflos M
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):728-38. PubMed ID: 18821260
[TBL] [Abstract][Full Text] [Related]
3. New N-pyridinyl(methyl)-indole-2- and 3-(alkyl)carboxamides and derivatives acting as systemic and topical inflammation inhibitors.
Breteche A; Duflos M; Dassonville A; Nourrisson MR; Brelet J; Le Baut G; Grimaud N; Petit JY
J Enzyme Inhib Med Chem; 2002 Dec; 17(6):415-24. PubMed ID: 12683678
[TBL] [Abstract][Full Text] [Related]
4. New N-pyridinyl(methyl)-N1-substituted-3-indolepropanamides acting as topical and systemic anti-inflammatory agents.
Gallard A; Duflos M; Nourrisson MR; Le Baut G; Grimaud N; Petit JY
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):201-8. PubMed ID: 12943205
[TBL] [Abstract][Full Text] [Related]
5. N-pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors.
Duflos M; Nourrisson MR; Brelet J; Courant J; LeBaut G; Grimaud N; Petit JY
Eur J Med Chem; 2001 Jun; 36(6):545-53. PubMed ID: 11525845
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 2-[1(2H)-phthalazinon-2-yl]acetamide and 3-[1(2H)-phthalazinon-2-yl]propanamide derivatives as antinociceptive and anti-inflammatory agents.
Dogruer DS; Kupeli E; Yesilada E; Sahin MF
Arch Pharm (Weinheim); 2004 Jun; 337(6):303-10. PubMed ID: 15188219
[TBL] [Abstract][Full Text] [Related]
8. New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.
Menciu C; Duflos M; Fouchard F; Le Baut G; Emig P; Achterrath U; Szelenyi I; Nickel B; Schmidt J; Kutscher B; Günther E
J Med Chem; 1999 Feb; 42(4):638-48. PubMed ID: 10052971
[TBL] [Abstract][Full Text] [Related]
9. Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents.
Carbonnelle D; Lardic M; Dassonville A; Verron E; Petit JY; Duflos M; Lang F
Eur J Med Chem; 2007 May; 42(5):686-93. PubMed ID: 17316917
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-pyridinyl(methyl)-1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamides and analogues and their anti-inflammatory activity in mice and rats.
Collin X; Robert JM; Duflos M; Wielgosz G; Le Baut G; Bobin-Dubigeon C; Grimaud N; Lang F; Petit JY
J Pharm Pharmacol; 2001 Mar; 53(3):417-23. PubMed ID: 11291760
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of ethanolic extract and alkamides-derived from Heliopsis longipes roots.
Hernández I; Márquez L; Martínez I; Dieguez R; Delporte C; Prieto S; Molina-Torres J; Garrido G
J Ethnopharmacol; 2009 Jul; 124(3):649-52. PubMed ID: 19439170
[TBL] [Abstract][Full Text] [Related]
12. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
[TBL] [Abstract][Full Text] [Related]
13. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents.
Radwan MA; Ragab EA; Sabry NM; El-Shenawy SM
Bioorg Med Chem; 2007 Jun; 15(11):3832-41. PubMed ID: 17395469
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological evaluation of indole derivatives acting as anti-inflammatory or antitumoral drugs].
Le Borgne M; Duflos M; Le Baut G; Nicholls PJ; Hartmann RW
Ann Pharm Fr; 2000 Oct; 58(5):316-20. PubMed ID: 11060408
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds.
Barlow JW; Walsh JJ
Eur J Med Chem; 2008 Dec; 43(12):2891-900. PubMed ID: 18406013
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-inflammatory activity of 5-(1,4-dihydropyridyl)-tetrazol-2-acetic acids, esters and amides.
Kumar P; Knaus EE
Drug Des Deliv; 1991 Jul; 7(4):287-94. PubMed ID: 1930621
[TBL] [Abstract][Full Text] [Related]
18. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiinflammatory activity of 5-(1,6-dihydropyridyl)-tetrazol-2-acetic acids, esters and amides.
Kumar P; Knaus EE
Drug Des Discov; 1994 Jan; 11(1):15-22. PubMed ID: 8068816
[TBL] [Abstract][Full Text] [Related]
20. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Yasukawa K; Iida T; Fujimoto Y
J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
